Jennison Associates’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,285
| Closed | -$1.35M | – | 598 |
|
|
2024
Q2 | $1.35M | Buy |
+3,285
| New | +$1.35M | ﹤0.01% | 464 |
|
|
2023
Q2 | – | Sell |
-1,330
| Closed | -$250K | – | 604 |
|
|
2023
Q1 | $250K | Sell |
1,330
-279
| -17% | -$52.5K | ﹤0.01% | 578 |
|
|
2022
Q4 | $342K | Buy |
+1,609
| New | +$342K | ﹤0.01% | 563 |
|
|
2022
Q1 | – | Sell |
-7,668
| Closed | -$1.67M | – | 679 |
|
|
2021
Q4 | $1.67M | Buy |
+7,668
| New | +$1.67M | ﹤0.01% | 554 |
|
|
2021
Q3 | – | Sell |
-14,061
| Closed | -$2.48M | – | 700 |
|
|
2021
Q2 | $2.48M | Buy |
14,061
+553
| +4% | +$97.7K | ﹤0.01% | 531 |
|
|
2021
Q1 | $2.22M | Sell |
13,508
-744
| -5% | -$122K | ﹤0.01% | 524 |
|
|
2020
Q4 | $1.98M | Buy |
14,252
+5,393
| +61% | +$751K | ﹤0.01% | 512 |
|
|
2020
Q3 | $990K | Sell |
8,859
-1,154
| -12% | -$129K | ﹤0.01% | 546 |
|
|
2020
Q2 | $931K | Buy |
10,013
+97
| +1% | +$9.02K | ﹤0.01% | 528 |
|
|
2020
Q1 | $728K | Buy |
9,916
+235
| +2% | +$17.3K | ﹤0.01% | 514 |
|
|
2019
Q4 | $814K | Sell |
9,681
-249
| -3% | -$20.9K | ﹤0.01% | 538 |
|
|
2019
Q3 | $835K | Sell |
9,930
-6,830
| -41% | -$574K | ﹤0.01% | 558 |
|
|
2019
Q2 | $1.1M | Buy |
16,760
+162
| +1% | +$10.6K | ﹤0.01% | 544 |
|
|
2019
Q1 | $979K | Buy |
16,598
+2,656
| +19% | +$157K | ﹤0.01% | 543 |
|
|
2018
Q4 | $738K | Buy |
13,942
+260
| +2% | +$13.8K | ﹤0.01% | 559 |
|
|
2018
Q3 | $820K | Sell |
13,682
-2,431
| -15% | -$146K | ﹤0.01% | 567 |
|
|
2018
Q2 | $693K | Buy |
+16,113
| New | +$693K | ﹤0.01% | 586 |
|